Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 484

2.
3.

Gag-specific immune enhancement of lentiviral infection after vaccination with an adenoviral vector in an animal model of AIDS.

Klonjkowski B, Klein D, Galea S, Gavard F, Monteil M, Duarte L, Fournier A, Sayon S, Górna K, Ertl R, Cordonnier N, Sonigo P, Eloit M, Richardson J.

Vaccine. 2009 Feb 5;27(6):928-39. doi: 10.1016/j.vaccine.2008.11.086. Epub 2008 Dec 12.

PMID:
19070641
4.

Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA.

Lockridge KM, Chien M, Dean GA, Stefano Cole K, Montelaro RC, Luciw PA, Sparger EE.

Virology. 2000 Jul 20;273(1):67-79.

5.

Cytokine modulation of the innate immune response in feline immunodeficiency virus-infected cats.

Dean GA, LaVoy A, Yearley J, Stanton C.

J Infect Dis. 2006 Jun 1;193(11):1520-7. Epub 2006 Apr 26.

PMID:
16652280
6.

Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.

Dean GA, LaVoy A, Burkhard MJ.

Vet Immunol Immunopathol. 2004 Jul;100(1-2):49-59.

PMID:
15182995
7.

Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus.

Flynn JN, Beatty JA, Cannon CA, Stephens EB, Hosie MJ, Neil JC, Jarrett O.

AIDS Res Hum Retroviruses. 1995 Sep;11(9):1107-13.

PMID:
8554908
8.

Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination.

Flynn JN, Keating P, Hosie MJ, Mackett M, Stephens EB, Beatty JA, Neil JC, Jarrett O.

J Immunol. 1996 Oct 15;157(8):3658-65.

PMID:
8871667
10.

FIV vaccine studies. I. Immune response to recombinant FIV env gene products and outcome after challenge infection.

Lutz H, Hofmann-Lehmann R, Bauer-Pham K, Holznagel E, Tozzini F, Bendinelli M, Reubel G, Aubert A, Davis D, Cox D, et al.

Vet Immunol Immunopathol. 1995 May;46(1-2):103-13.

PMID:
7618250
11.

Induction of serum and mucosal FIV-specific immune responses by intranasal immunization with p24Gag.

Leavell S, Wright B, Scappino L, Sirriyah J, Chen C, Clements JD, Burkhard MJ.

Vaccine. 2005 Feb 10;23(12):1471-8.

PMID:
15670883
12.

Induction of feline immunodeficiency virus-specific cytotoxic T cells in vivo with carrier-free synthetic peptide.

Flynn JN, Cannon CA, Beatty JA, Mackett M, Rigby MA, Neil JC, Jarrett C.

J Virol. 1994 Sep;68(9):5835-44.

13.
14.
15.

Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.

Liang X, Casimiro DR, Schleif WA, Wang F, Davies ME, Zhang ZQ, Fu TM, Finnefrock AC, Handt L, Citron MP, Heidecker G, Tang A, Chen M, Wilson KA, Gabryelski L, McElhaugh M, Carella A, Moyer C, Huang L, Vitelli S, Patel D, Lin J, Emini EA, Shiver JW.

J Virol. 2005 Oct;79(19):12321-31.

16.

Molecular subtyping of feline immunodeficiency virus from cats in Melbourne.

Iwata D, Holloway SA.

Aust Vet J. 2008 Oct;86(10):385-9. doi: 10.1111/j.1751-0813.2008.00336.x.

PMID:
18826508
17.

Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys.

Someya K, Xin KQ, Ami Y, Izumi Y, Mizuguchi H, Ohta S, Yamamoto N, Honda M, Okuda K.

Virology. 2007 Oct 25;367(2):390-7. Epub 2007 Jul 12.

18.

Feline immunodeficiency virus Gag- and Env-specific immune responses after vaginal versus intravenous infection.

Burkhard MJ, Mathiason CK, Bowdre T, Hoover EA.

AIDS Res Hum Retroviruses. 2001 Dec 10;17(18):1767-78.

PMID:
11788028

Supplemental Content

Support Center